198 related articles for article (PubMed ID: 1577391)
21. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
[TBL] [Abstract][Full Text] [Related]
22. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
23. Sucralfate used as adjunctive therapy in patients with severe erosive peptic esophagitis resulting from gastroesophageal reflux.
Herrera JL; Shay SS; McCabe M; Peura DA; Johnson LF
Am J Gastroenterol; 1990 Oct; 85(10):1335-8. PubMed ID: 2220725
[TBL] [Abstract][Full Text] [Related]
24. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
Fiorucci S; Santucci L; Morelli A
Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
[TBL] [Abstract][Full Text] [Related]
25. Pattern of acid reflux in patients with reflux esophagitis 'resistant' to H2-receptor antagonists.
Bianchi Porro G; Pace F; Sangaletti O
Scand J Gastroenterol; 1990 Aug; 25(8):810-4. PubMed ID: 1976270
[TBL] [Abstract][Full Text] [Related]
26. Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux.
Mine S; Fujisaki T; Tabata T; Matsuoka H; Iida T; Yamada S; Tanaka Y; Morimoto I; Eto S; Aibe T
Am J Gastroenterol; 2000 Feb; 95(2):381-6. PubMed ID: 10685739
[TBL] [Abstract][Full Text] [Related]
27. Famotidine in the management of gastro-oesophageal reflux.
Okoth FA; Lule GN; Ogutu EO; Pilczer S; Dubois C
East Afr Med J; 1994 Jan; 71(1):44-8. PubMed ID: 8055765
[TBL] [Abstract][Full Text] [Related]
28. Double-blind crossover study of ranitidine and ebrotidine in gastro-esophageal reflux disease.
Sito E; Thor PJ; M[aczka M; Lorens K; Konturek SJ; Maj A
J Physiol Pharmacol; 1993 Sep; 44(3):259-72. PubMed ID: 8241527
[TBL] [Abstract][Full Text] [Related]
29. Ranitidine versus cimetidine in the healing of erosive esophagitis.
McCarty-Dawson D; Sue SO; Morrill B; Murdock RH
Clin Ther; 1996; 18(6):1150-60. PubMed ID: 9001831
[TBL] [Abstract][Full Text] [Related]
30. Gastric and esophageal acidity during continuous treatment with H2-antagonists in uncomplicated esophagitis.
Fiorucci S; Santucci L; Perrone E; Abbritti F; Morelli A
Scand J Gastroenterol; 1989 Aug; 24(6):671-7. PubMed ID: 2573143
[TBL] [Abstract][Full Text] [Related]
31. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of H2 receptor antagonists in the treatment of gastroesophageal reflux disease and its symptoms.
Tougas G; Armstrong D
Can J Gastroenterol; 1997 Sep; 11 Suppl B():51B-54B. PubMed ID: 9347179
[TBL] [Abstract][Full Text] [Related]
33. [Comparative efficacy of famotidine and ranitidine in the treatment of acute-phase duodenal ulcer. A French comparative therapeutic trial].
Delvaux M; Hagège CG; Ribet A
Gastroenterol Clin Biol; 1989 Dec; 13(12):1055-9. PubMed ID: 2696659
[TBL] [Abstract][Full Text] [Related]
34. Ranitidine in the management of gastro-oesophageal reflux disease.
Nelis GF
Neth J Med; 1985; 28(5):197-200. PubMed ID: 3892319
[No Abstract] [Full Text] [Related]
35. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of gastroesophageal reflux: analysis of randomized double-blind trials].
Pignon JP; Poynard T; Naveau S; Sebag G; Chaput JC
Gastroenterol Clin Biol; 1987 Oct; 11(10):668-80. PubMed ID: 2891580
[TBL] [Abstract][Full Text] [Related]
37. [Role of 24 hour intraesophageal pH monitoring in diagnosis of gastroesophageal reflux and assessment of drug effectiveness].
Abidin ZU; Ivashkin VT; Sheptulin AA; Trukhmanov AS; Okhlobystin AV
Klin Med (Mosk); 1999; 77(7):39-42. PubMed ID: 10483164
[TBL] [Abstract][Full Text] [Related]
38. [Gastroesophageal reflux].
Schwizer W; Fried M
Ther Umsch; 1997 Nov; 54(11):611-6. PubMed ID: 9454361
[TBL] [Abstract][Full Text] [Related]
39. Drug therapy of peptic ulcer disease.
Ching CK; Lam SK
Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
[TBL] [Abstract][Full Text] [Related]
40. Minimal change oesophagitis: a disease with characteristic differences to erosive oesophagitis.
Nakamura T; Shirakawa K; Masuyama H; Sugaya H; Hiraishi H; Terano A
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():19-26. PubMed ID: 15943842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]